HC-based NGS impacts treatment decisions in lung cancer patients with adenocarcinoma

(International Association for the Study of Lung Cancer) The use of hybrid capture-based next-generation sequencing to identify targetable oncogenic drivers in patients with lung adenocarcinoma results in the detection of genomic alterations not identified in routine screening, and impacts treatment decisions and clinical outcomes.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news